PART B: VALORISATION PLAN
SECTION I: ESTIMATION OF COSTS
|
1 |
Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
| … in terms of IPR protection | |
| The patent has not yet been registered, but the methodology should be protected.
Costs can be considered not relevant.
|
|
| …in terms of product development | |
| The production of catalysts at industrial level, applying the present methodology, in collaboration with an industrial partner, can be considered circa 100.000€.
|
|
| …in terms of mass production | |
| n.a.
|
|
| … in terms of marketing | |
| n.a. | |
|
2 |
Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs |
|||||
|
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
|
Fixed costs |
|
|
|
|
|
|
|
Personnel |
|
|
|
|
|
|
|
Other running costs |
|
|
|
|
|
|
|
Marketing costs |
|
|
|
|
|
|
|
TOTAL EXPECTED COSTS |
|
|
|
|
|
|
|
Price per Unit |
|
|
|
|
|
|
|
Type of Unit |
|
|||||
|
Number of Units |
|
|
|
|
|
|
|
TOTAL Expected Revenues |
|
|
|
|
|
|
|
CASH FLOW REQUIRED (REVENUES-COSTS) |
|
|
|
|
|
|
|
TOTAL CAPITAL required for five years |
n.a. |
|||||
SECTION 2: QUALITATIVE FACTORS
|
3 |
Dimension of identified target groups |
| The main target group is represented by industries producing catalysts applied in different sectors, such as heating plantations, chemical and technical processes, gas industries, automotive industries.
|
|
|
4 |
Evaluation of financial Risks for R&D result |
| No particular financial risks to be underlined for R&D result. An investment for the engineering is needed in terms of skilled staff/researchers
|
|
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)
|
1. European Funding Define relevance of the product with the following potential funding sources and comment |
|
1. FP7 – NMP work programme to be explored with attention to Cooperation calls http://cordis.europa.eu/fp7/cooperation/nanotechnology_en.html
http://cordis.europa.eu/nanotechnology/src/intlcoop.htm For further develop the Research, the two above mentioned EU programmes can be addressed. It is suggested to monitor the Nanotechnology home page of the EC for information about calls and initiatives in the selected field: http://cordis.europa.eu/nanotechnology/
|
|
2. National Funding |
|
n.a.
|
|
3. Private funding |
|
n.a.
|
|
4. Other |
|
For the product engineering, the collaboration with an industrial partner is recommended.
|
SECTION 3: FINAL EVALUATION
| It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)… |
| A specific product has not yet been developed, but several publications and studies confirm the validity of the developed methodology. The patent should be registered.
A particular interest in the engineering phase has been expressed by an automotive industry, but the collaboration has not yet been started. The adaptability of the methodology to the different possible requests and different sectors where catalysts can be used, is an important characteristic but not enough to prove the real potential. The R&D result at this stage needs still some revisions.
|
Decision of evaluation (Please keep only the appropriate)
- The R&D has a high potential of exploitation
- The R&D result needs minor revisions
- The R&D result needs moderate revisions
- The R&D result needs major revisions
- The R&D result has no potential of exploitation
Romina Kocina
Fabio Santarossa
